4//SEC Filing
Futro Peter G 4
Accession 0001140361-05-004304
CIK 0001095963other
Filed
Jun 2, 8:00 PM ET
Accepted
Jun 3, 5:43 PM ET
Size
15.9 KB
Accession
0001140361-05-004304
Insider Transaction Report
Form 4
US MEDSYS CORPUMSY
Futro Peter G
DirectorChm, Pres, CEO & Treasurer10% Owner
Transactions
- Other
Common Stock
2005-01-10−500,000→ 7,353,537 total(indirect: By Rangeley Corporation) - Other
Common Stock
2005-03-18−257,626→ 7,095,911 total(indirect: By Rangeley Corporation) - Sale
Common Stock
2004-09-29−412,200→ 7,853,537 total(indirect: By Rangeley Corporation) - Other
Common Stock
2005-04-22−214,872→ 6,881,039 total(indirect: By Rangeley Corporation) - Sale
Common Stock
2004-08-27−20,000→ 8,265,737 total(indirect: By Rangeley Corporation) - Sale
Common Stock
2004-05-31−600,000→ 8,285,737 total(indirect: By Rangeley Corporation)
Footnotes (7)
- [F1]600,000 shares of restricted common stock were transferred by Rangeley Corporation in a non-market, private transaction, to third-parties for services valued at $1.75 per share.
- [F2]20,000 shares of restricted common stock were sold by Rangeley Corporation in a non-market, private transaction, to Robert Shea and Mark Franz, officers of the Issuer's subsidiary, GMD, LLC, for a cash amount of $2.50 per share.
- [F3]412,200 shares of restricted common stock were sold by Rangeley Corporation in a non-market, private transaction, to third-parties for a cash amount of $1.75 per share. The third-parties have the right to buy an additional 343,500 shares of restricted common stock from Rangeley Corporation for $1.00 per share until September 29, 2006.
- [F4]500,000 shares of restricted common stock were transferred by Rangeley Corporation in a non-market, private transaction, to a third-party in exchange for services valued at $1.75 per share.
- [F5]257,626 shares of restricted common stock were transferred by Rangeley Corporation in a non-market, private transaction, to third-parties involved in previously reported transactions as a subsequent adjustment negotiated by the parties. No additional consideration was received.
- [F6]214,872 shares of restricted common stock were transferred by Rangeley Corporation in a non-market, private transaction, to third-parties involved in previously reported transactions as a subsequent adjustment negotiated by the parties. No additional consideration was received.
- [F7]The amount in the Table reflects the number of shares owned by Rangeley Corporation following the reported transaction. In addition, 560,000 shares are owned directly by the Reporting Person, and 270,000 shares are owned by Futro & Associates, P.C.
Documents
Issuer
US MEDSYS CORP
CIK 0001095963
Entity typeother
Related Parties
1- filerCIK 0001295444
Filing Metadata
- Form type
- 4
- Filed
- Jun 2, 8:00 PM ET
- Accepted
- Jun 3, 5:43 PM ET
- Size
- 15.9 KB